Dr. Eduardo Gabriel Ortiz, MD

Dr. Ortiz practices at Geisinger Medical Center in Danville, Pennsylvania, part of Risant Health.

Dr. Ortiz's NPI, 1629537659, was assigned on March 19, 2019. Dr. Ortiz holds Pennsylvania license MD480839.

Dr. Ortiz's primary practice is Geisinger Medical Center, at 100 North Academy Avenue, Danville, PA 17822 in Montour County. The practice phone is (570) 271-6211.

Dr. Ortiz's primary practice is Geisinger Medical Center in Danville, Pennsylvania, part of Risant Health. Dr. Ortiz is also affiliated with Geisinger Wyoming Valley Medical Center. The medical group on file is Geisinger. Dmand AI also links Dr. Ortiz to 2 more group practices and clinics and 1 medical group, each named with a free account.

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Ortiz practices, 4 sites in all. Vendor and product names are available with a free account.

Dermatology is Dr. Ortiz's primary specialty in the NPI Registry, under taxonomy code 207N00000X. Dr. Ortiz is licensed in Pennsylvania.

CMS data shows 1,179 Medicare services from Dr. Ortiz across 13 procedure codes in 2024, for 430 Medicare patients. Medicare paid $41,573 for them. Every service was in an office.

CMS counts 430 Medicare patients who saw Dr. Ortiz in 2024. The largest group is 65 to 74, with 196 patients. 75% of them have high cholesterol, and 72% have high blood pressure. 10% are also on Medicaid. Their average risk score is 1.12, where 1.00 is the Medicare average.

Across all payers, Dmand AI patient panel data puts Dr. Ortiz's median patient age at 73, with 53% women.

In 2024, Dr. Ortiz wrote 702 Medicare Part D claims for 259 patients. 87% of them were for generic drugs. CMS names the drug for 543 of them, across 14 drugs with 11 or more claims each, at $187,044 in total drug cost. In 2023, CMS named 212 claims across 10 drugs.

Dr. Ortiz accepts Medicare assignment, so Medicare's approved amount is taken as full payment. CMS counts 251 procedures of removal of skin lesions by Dr. Ortiz, more than 81% of the clinicians it reports for that procedure.

Melanoma (skin cancer) excision: 1 to 10 procedures (CMS shows small counts as a range)

Dmand AI links 2 papers to Dr. Ortiz, published from 2022 to 2023. Dr. Ortiz has published most often in J Cutan Pathol.

CMS Open Payments shows 1 general payment to Dr. Ortiz from 1 drug or device company in 2022. Food and beverage make up the largest share, 100% of the total. Bristol-Myers Squibb Company paid the most, $95.